Top Markets
Coin of the day
LungLife AI, Inc. LungLife AI, Inc.

LungLife AI, Inc.

LLAI
株式のランク #41525
LungLife AI, Inc. is a clinical diagnostics enterprise focused on creating... LungLife AI, Inc. is a clinical diagnostics enterprise focused on creating AI-powered solutions for detecting lung cancer. The company is actively developing LungLB, an advanced blood-based test that harnesses artificial intelligence and machine learning. LungLB is designed to precisely identify and quantify circulating tumor cells (CTCs), ultimately aiming to minimize manual intervention and elevate diagnostic performance. The organization, which was previously known as Cynvenio Biosystems, Inc., adopted the LungLife AI, Inc. moniker in May of 2019. Its operations are based in Thousand Oaks, California.
株価
$0.05646911
最終同期: 2025-05-28
時価総額
$17.31K
変化(1日)
-1.67%
変化(1年)
0.00%
US
取引 LungLife AI, Inc. (LLAI)

カテゴリー

LungLife AI, Inc.(LLAI)の配当利回りの履歴
LungLife AI, Inc.(銘柄コード: LLAI)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
LungLife AI, Inc.(LLAI)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)